On November 23, 2016, CHIL signed a notarized agreement with another leading company in the Kingdom of Saudi Arabia for a new project involving its high-risk group EIA screening kits and fully automated EIA analyzers.
The agreement formalized the scope of collaboration under a regulated screening framework, further strengthening CHIL’s operational presence in the Saudi healthcare market.